Lamb Weston reported quarterly earnings of $1.10 per share which beat the analyst consensus estimate of 87 cents per share.

The Aspergillosis market is expected to surge due to the disease's increasing prevalence and awareness during the forecast ...

Dupilumab treatment of atopic dermatitis resulted in long-term skin improvements linked to changes in skin’s the molecular composition.

Australian biotech major CSL Limited (ASX: CSL) subsidiary CSL Behring today announced that it has successfully concluded ...

Colorado-based Edgewise Therapeutics, a muscle disease-focused biopharma company, closed 23% lower after Wednesday’s trading.

Over the years, there have been significant changes to the dyslipidemia medication management guidelines, alongside ...

Music, film, fashion, design and gaming are entering a new era where technological innovation is redefining creation, distribution and consumer experience. VivaTech will honor the creative industries ...